Assessing efficacy and tolerability of a modified lenalidomide/bortezomib/dexamethasone (VRd-28) regimen using weekly bortezomib in multiple myeloma
Publication/Presentation Date
10-2019
Volume
19
Issue
10
First Page
217
Last Page
218
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Fellows and Residents
Document Type
Article
COinS